Updated: CR Pharma $2bn IPO nets big name cornerstones
China Resources Pharmaceutical Group has lined up eight cornerstone investors for its HK$15.6bn ($2.0bn) Hong Kong IPO, with the group agreeing to buy $916m worth of shares.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: